Abivax (ABVX) is up 16.1%, or $18.50 to $133.44.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABVX:
- Why Is Abivax (ABVX) Stock Rallying Today?
- – Abivax SA American Depositary Shares call volume above normal and directionally bullish
- Abivax to be added to Nasdaq Biotechnology Index
- Abivax price target raised to $175 from $150 at Guggenheim
- Abivax price target raised to $142 from $112 at Piper Sandler